ARCHIVES

Group Chairs Urge NCI to Limit Authority of Steering Committees That Determine Which Trials Get Funded

This article is from The Cancer Letter archive.

Vol. 37 No. 31 | August 5, 2011

Download PDF Visit The Full Archive

Related Articles

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals

April 18, 1986

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

August 9, 2013

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards

February 12, 1999